nach oben

Erschienen in:

13.02.2021 | Original Article

Alpha thalassemia, but not β^S-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort

verfasst von: Betânia Lucena Domingues Hatzlhofer, Diego Antonio Pereira-Martins, Igor de Farias Domingos, Gabriela da Silva Arcanjo, Isabel Weinhäuser, Diego Arruda Falcão, Isabela Cristina Cordeiro Farias, Jéssica Vitória Gadelha de Freitas Batista, Luana Priscilla Laranjeira Prado, Jéssica Maria Florencio Oliveira, Thais Helena Chaves Batista, Marcondes José de Vasconcelos Costa Sobreira, Rodrigo Marcionilo de Santana, Amanda Bezerra de Sá Araújo, Manuela Albuquerque de Melo, Bruna Vasconcelos de Ancântara, Juan Luiz Coelho-Silva, Ana Beatriz Lucas de Moura Rafael, Danízia Menezes de Lima Silva, Flávia Peixoto Albuquerque, Magnun Nueldo Nunes Santos, Ana Cláudia dos Anjos, Fernando Ferreira Costa, Aderson da Silva Araújo, Antonio Roberto Lucena-Araújo, Marcos André Cavalcanti Bezerra

Erschienen in: Annals of Hematology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Alpha thalassemia and beta-globin haplotype are considered classical genetic disease modifiers in sickle cell anemia (SCA) causing clinical heterogeneity. Nevertheless, their functional impact on SCA disease emergence and progression remains elusive. To better understand the role of alpha thalassemia and beta-globin haplotype in SCA, we performed a retrospective study evaluating the clinical manifestations of 614 patients. The univariate analysis showed that the presence of alpha-thalassemia −3.7-kb mutation (αα/-α and -α/-α) decreased the risk of stroke development (p = 0.046), priapism (p = 0.033), and cholelithiasis (p = 0.021). Furthermore, the cumulative incidence of stroke (p = 0.023) and cholelithiasis (p = 0.006) was also significantly lower for patients carrying the alpha thalassemia −3.7-kb mutation. No clinical effects were associated with the beta-globin haplotype analysis, which could be explained by the relatively homogeneous haplotype composition in our cohort. Our results reinforce that alpha thalassemia can provide protective functions against hemolysis-related symptoms in SCA. Although, several genetic modifiers can impact the inflammatory state of SCA patients, the alpha thalassemia mutation remains one of the most recurrent genetic aberration and should therefore always be considered first.

Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, Wang WC, Hoppe C, Hagar W, Darbari DS, Malik P (2012) Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. Sci World J 2012:1–55. https://doi.org/10.1100/2012/949535CrossRef

Driss A, Asare K, Hibbert J et al (2009) Sickle cell disease in the post genomic era: a monogenic disease with a polygenic phenotype. Genomics Insights 2009:23–48PubMed

Serjeant GR (2013) The natural history of sickle cell disease. Cold Spring Harb Perspect Med 3:1–11. https://doi.org/10.1101/cshperspect.a011783CrossRef

Kutlar A (2007) Sickle cell disease: a multigenic perspective of a single gene disorder. Hemoglobin 31:209–224. https://doi.org/10.1080/03630260701290233CrossRefPubMed

Steinberg MH, Embury SH (1986) Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood 68:985–990CrossRef

Powars DR (1991) Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol Oncol Clin North Am 5:475–493CrossRef

Zago MA, Pinto ACS (2007) Fisiopatologia das doenças falciformes: da mutação genética à insuficiência de múltiplos órgãos. Rev Bras Hematol Hemoter 29:207–214. https://doi.org/10.1590/S1516-84842007000300003CrossRef

Silva Lilianne B, Gonçalves Romélia P (2010) Características fenotípicas dos pacientes com anemia falciforme de acordo com os haplótipos do gene da βS-globina em Fortaleza, Ceará. Rev Bras Hematol Hemoter 32(1):40–44. https://doi.org/10.1590/S1516-84842010005000005CrossRef

Shimauti ELT, Humberto Silva DG, Menezes de Souza E et al (2015) Prevalence of b -globin gene haplotypes , a -thalassemia ( 3 . 7 kb deletion ) and redox status in patients with sickle cell anemia in the state of Paraná , Brazil. Genet Mol Biol 323:316–323. https://doi.org/10.1590/S1415-475738320140231CrossRef

10.

Serjeant GR, Vichinsky E, Herrick J, Mason V (2017) Variability of homozygous sickle cell disease: the role of alpha and beta globin chain variation and other factors. Blood Cells Mol Dis 70:0–1. https://doi.org/10.1016/j.bcmd.2017.06.004

11.

Steinberg MH (2005) Predicting clinical severity in sickle cell anaemia. Br J Haematol 129:465–481. https://doi.org/10.1111/j.1365-2141.2005.05411.xCrossRefPubMed

12.

Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21:37–47. https://doi.org/10.1016/j.blre.2006.07.001CrossRefPubMed

13.

Nolan VG, Wyszynski DF, Farrer LA, Steinberg MH (2005) Hemolysis-associated priapism in sickle cell disease. Blood 106:3264–3267. https://doi.org/10.1182/blood-2005-04-1594CrossRefPubMedPubMedCentral

14.

Vasavda N, Menzel S, Kondaveeti S, Maytham E, Awogbade M, Bannister S, Cunningham J, Eichholz A, Daniel Y, Okpala I, Fulford T, Thein SL (2007) The linear effects of a-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol 138:263–270. https://doi.org/10.1111/j.1365-2141.2007.06643.xCrossRefPubMed

15.

Fertrin KY, Costa FF (2010) Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment. Expert Rev Hematol 3:443–458. https://doi.org/10.1586/ehm.10.44CrossRefPubMed

16.

Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, Sable C, Ensing G, Dham N, Campbell A, Arteta M, Gladwin MT, Castro O, Taylor JG VI, Kato GJ, Gordeuk V (2012) Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr 160:286–290. https://doi.org/10.1016/j.jpeds.2011.07.018CrossRefPubMed

17.

Alkindi SY, Pathare A, Al Zadjali S, Panjwani V, Wasim F, Khan H, Chopra P, Krishnamoorthy R, Alkindi S (2015) Serum Total Bilirubin, not Cholelithiasis, is Influenced by UGT1A1 Polymorphism, Alpha Thalassemia and β(s) Haplotype: First Report on Comparison between Arab-Indian and African β(s) Genes. Mediterr J Hematol Infect Dis 7(1):e2015060. https://doi.org/10.4084/mjhid.2015.060CrossRefPubMedPubMedCentral

18.

Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR (1992) Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120:360–366. https://doi.org/10.1016/S0022-3476(05)80897-2CrossRefPubMed

19.

Ballas SK, Talacki CA, Rao VM, Steiner RM (1989) The prevalence of avascular necrosis in sickle cell anemia: correlation with αthalassemia. Hemoglobin 13:649–655. https://doi.org/10.3109/03630268908998842CrossRefPubMed

20.

Steinberg MH (2009) Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal 9:46–67. https://doi.org/10.1100/tsw.2009.10CrossRefPubMedPubMedCentral

21.

Joly P, Pondarré C, Bardel C, Francina A, Martin C (2012) The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score. Eur J Haematol 88:61–67. https://doi.org/10.1111/j.1600-0609.2011.01705.xCrossRefPubMed

22.

Kato GJ, Steinberg MH, Gladwin MT (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 127:750–760. https://doi.org/10.1172/JCI89741CrossRefPubMedPubMedCentral

23.

Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DHK, Steinberg MH (2011) Fetal hemoglobin in sickle cell anemia. Blood 118:19–27. https://doi.org/10.1182/blood-2011-03-325258CrossRefPubMedPubMedCentral

24.

McGann PT, Ware RE (2015) Hydroxyurea therapy for sickle cell anemia. Expert Opin Drug Saf 42:407–420. https://doi.org/10.1002/jmri.24785.Free-BreathingCrossRef

25.

Nagel RL, Fabry ME, Pagnier J, Zohoun I, Wajcman H, Baudin V, Labie D (1985) Hematologically and genetically distinct forms of sickle cell anemia in Africa. N Engl J Med 312:880–884. https://doi.org/10.1056/NEJM198504043121403CrossRefPubMed

26.

Rusanova I, Escames G, Cossio G, de Borace RG, Moreno B, Chahboune M, López LC, Díez T, Acuña-Castroviejo D (2010) Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease. Eur J Haematol 85:529–537. https://doi.org/10.1111/j.1600-0609.2010.01528.xCrossRefPubMed

27.

Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, Labie D (1984) Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci U S A 81:1771–1773. https://doi.org/10.1073/pnas.81.6.1771CrossRefPubMedPubMedCentral

28.

Rahgozar S, Poorfathollah AA, Moafi AR, Old JM (2000) BS gene in Central Iran is in linkage disequilibrium with the Indian – Arab haplotype. Am J Hematol 195:192–195CrossRef

29.

Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease. N Engl J Med 376:1561–1573. https://doi.org/10.1056/NEJMra1510865CrossRefPubMed

30.

Steinberg MH, Sebastiani P (2012) Genetic modifiers of sickle cell disease. Am J Hematol 87:795–803. https://doi.org/10.1002/ajh.23232CrossRefPubMedPubMedCentral

31.

Powars D, Chan L, Schroed WA (1990) βS-gene-cluster haplotypes in sickle cell anemia: clinical implications. Am J Pediatr Hematol Oncol 12:367–374CrossRef

32.

Adekile AD (2005) Mild-phenotype sickle cell disease: molecular basis, clinical presentation and management recommendations. Curr Paediatr 15:57–61. https://doi.org/10.1016/j.cupe.2004.10.009CrossRef

33.

Cabral CHK, Serafim ÉSS, de Medeiros WRDB et al (2011) Determination of βS haplotypes in patients with sickle-cell anemia in the state of Rio Grande do Norte, Brazil. Genet Mol Biol 34:421–424. https://doi.org/10.1590/S1415-47572011005000027CrossRefPubMedPubMedCentral

34.

Loggetto SR (2013) Sickle cell anemia: clinical diversity and beta S-globin haplotypes. Rev Bras Hematol Hemoter 35:155–157. https://doi.org/10.5581/1516-8484.20130048CrossRefPubMedPubMedCentral

35.

Thein SL, Menzel S, Peng X, Best S, Jiang J, Close J, Silver N, Gerovasilli A, Ping C, Yamaguchi M, Wahlberg K, Ulug P, Spector TD, Garner C, Matsuda F, Farrall M, Lathrop M (2007) Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci U S A 104:11346–11351. https://doi.org/10.1073/pnas.0611393104CrossRefPubMedPubMedCentral

36.

Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, Usala G, Busonero F, Maschio A, Albai G, Piras MG, Sestu N, Lai S, Dei M, Mulas A, Crisponi L, Naitza S, Asunis I, Deiana M, Nagaraja R, Perseu L, Satta S, Cipollina MD, Sollaino C, Moi P, Hirschhorn JN, Orkin SH, Abecasis GR, Schlessinger D, Cao A (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of -thalassemia. Proc Natl Acad Sci 105:1620–1625. https://doi.org/10.1073/pnas.0711566105CrossRefPubMed

37.

Liu L, Pertsemlidis A, Ding L-H, Story MD, Steinberg MH, Sebastiani P, Hoppe C, Ballas SK, Pace BS (2016) Original research: a case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease. Exp Biol Med 241:706–718. https://doi.org/10.1177/1535370216642047CrossRef

38.

Menzel S, Thein SL (2019) Genetic modifiers of fetal haemoglobin in sickle cell disease. Mol Diagnosis Ther 23:235–244. https://doi.org/10.1007/s40291-018-0370-8CrossRef

39.

Chang Y, Smith K, Moore R, Serjeant GR, Dover GJ (1995) An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age. Blood 85:1111–1117CrossRef

40.

Belisario AR, Martins ML, Brito AMS et al (2010) b-Globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or Sb-thalassemia and their association with clinical and hematological features. Acta Haematol 124:162–170. https://doi.org/10.1159/000320271CrossRefPubMed

41.

Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, Diamond S, Holbrook CT, Gill FM, Ritchey K, Falletta JM, For the Prophylactic Penicillin Study Group (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med 314:1593–1599. https://doi.org/10.1056/NEJM198606193142501CrossRefPubMed

42.

Silveira, E. L., da Rocha Silla, L. M., Krug, B. C., & Amaral, K. M. (2010). Doença Falciforme. Protocolo Clínico e Diretrizes Terapeuticas.

43.

Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317–1322. https://doi.org/10.1056/nejm199505183322001CrossRefPubMed

44.

Baldwin C, Nolan VG, Wyszynski DF, Ma QL, Sebastiani P, Embury SH, Bisbee A, Farrell J, Farrer L, Steinberg MH (2005) Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 106:372–375. https://doi.org/10.1182/blood-2005-02-0548CrossRefPubMedPubMedCentral

45.

Nolan VG, Baldwin C, Ma Q, Wyszynski DF, Amirault Y, Farrell JJ, Bisbee A, Embury SH, Farrer LA, Steinberg MH (2005) Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol 128:266–272. https://doi.org/10.1111/j.1365-2141.2004.05295.xCrossRefPubMed

46.

Nolan VG, Adewoye A, Baldwin C, Wang L, Ma Q, Wyszynski DF, Farrell JJ, Sebastiani P, Farrer LA, Steinberg MH (2006) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-β/BMP pathway. Br J Haematol 133:570–578CrossRef

47.

Davis LG, Dibner MD, Battey JF (1986) Basic methods in molecular biology, 1st edn. Elsevier Science Publishing, New York, NY

48.

Sutton M, Bouhassira EE, Nagel RL (1989) Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes. Am J Hematol 32:66–69. https://doi.org/10.1002/ajh.2830320113CrossRefPubMed

49.

Dodé C, Krishnamoorthy R, Lamb J, Rochette J (1993) Rapid analysis of -α 3.7 thalassaemia and ααα anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 83:105–111. https://doi.org/10.1111/j.1365-2141.1993.tb04639.xCrossRefPubMed

50.

Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP (2018) Sickle cell disease. Nat Rev Dis Prim 4. https://doi.org/10.1038/nrdp.2018.10

51.

Conran N, Belcher JD (2018) Inflammation in sickle cell disease. Clin Hemorheol Microcirc 68:263–299. https://doi.org/10.3233/CH-189012CrossRefPubMedPubMedCentral

52.

Noubouossie D, Key NS, Ataga KI (2016) Coagulation abnormalities of sickle cell disease: relationship with clinical outcomes and the effect of disease modifying therapies. Blood Rev 30:245–256. https://doi.org/10.1016/j.blre.2015.12.003CrossRefPubMed

53.

Nasimuzzaman M, Malik P (2019) Role of the coagulation system in the pathogenesis of sickle cell disease. Blood Adv 3:3170–3180. https://doi.org/10.1182/bloodadvances.2019000193CrossRefPubMedPubMedCentral

54.

Kim-Shapiro DB, Gladwin MT (2018) Nitric oxide pathology and therapeutics in sickle cell disease. Clin Hemorheol Microcirc 68:223–237. https://doi.org/10.3233/CH-189009CrossRefPubMedPubMedCentral

55.

Belisario AR, Rodrigues CV, Martins ML et al (2010) Coinheritance of α-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia. Hemoglobin 34:516–529. https://doi.org/10.3109/03630269.2010.526003CrossRefPubMed

56.

Adorno EV, Zanette Â, Lyra I, Seixas MO, Reis MG, Gonçalves MS (2008) Clinical and molecular characteristics of sickle cell anemia in the northeast of Brazil. Genet Mol Biol 31:621–625. https://doi.org/10.1590/S1415-47572008000400003CrossRef

57.

Neonato MG, Guilloud-Bataille M, Beauvais P, Bégué P, Belloy M, Benkerrou M, Ducrocq R, Maier-Redelsperger M, de Montalembert M, Quinet B, Elion J, Feingold J, Girot R, French Study Group on Sickle Cell Disease (2000) Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol 65:155–164. https://doi.org/10.1034/j.1600-0609.2000.90210.xCrossRefPubMed

58.

Castro O, Brambilla D, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 84:643–649CrossRef

59.

Arends A, Alvarez M, Velázquez D, Bravo M, Salazar R, Guevara JM, Castillo O (2000) Determination of b-globin gene cluster haplotypes and prevalence of a-thalassemia in sickle cell anemia patients in Venezuela. Am J Hematol 64:87–90CrossRef

60.

Koshy M, Entsuah R, Koranda A, Kraus AP, Johnson R, Bellvue R, Flournoy-Gill Z, Levy P (1989) Leg ulcers in patients with sickle cell disease. Blood 74:1403–1408CrossRef

61.

Adams RJ, Kutlar A, McKie V, Carl E, Nichols FT, Liu JC, McKie K, Clary A (1994) Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol 45:279–282. https://doi.org/10.1002/ajh.2830450402CrossRefPubMed

62.

Flanagan JM, Frohlich DM, Howard TA et al (2011) Genetic predictors for stroke in children with sickle cell anemia. Blood 117:6681–6684. https://doi.org/10.1182/blood-2011-01-332205CrossRefPubMedPubMedCentral

63.

Joly P, Garnier N, Kebaili K, Renoux C, Dony A, Cheikh N, Renard C, Ceraulo A, Cuzzubbo D, Pondarré C, Martin C, Pialoux V, Francina A, Bertrand Y, Connes P (2016) G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia. Eur J Haematol 96:404–408. https://doi.org/10.1111/ejh.12607CrossRefPubMed

64.

Ohene-Frempong K, Weiner SJ, Sleeper LA et al (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288–294PubMed

65.

Adams GT, Snieder H, McKie VC et al (2003) Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med Genet 4:6. https://doi.org/10.1186/1471-2350-4-6CrossRefPubMedPubMedCentral

66.

Steinberg MH, Rodgers GP (2001) Pathophysiology of sickle cell disease: role of cellular and genetic modifiers. Semin Hematol 38:299–306CrossRef

67.

Chaar V, Diara JP, Clayton J (2005) Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica 90:188–193PubMed

68.

Powars DR, Hiti A, Ramicone E, Johnson C, Chan L (2002) Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol 70:206–215. https://doi.org/10.1002/ajh.10140CrossRefPubMed

69.

Curro G, Meo A, Ippolito D et al (2007) Asymptomatic cholelithiasis in children with sickle cell disease. Ann Surg 245:126–129. https://doi.org/10.1097/01.sla.0000242716.66878.23CrossRefPubMedPubMedCentral

70.

Haider MZ, Ashebu S, Aduh P, Adekile AD (1998) Influence of a-thalassemia on cholelithiasis in SS patients with elevated Hb F. Acta Haematol 100:147–150. https://doi.org/10.1159/000040890CrossRefPubMed

71.

Parody R, Rabella N, Martino R, Otegui M, del Cuerpo M, Coll P, Sierra J (2007) UGT1A1 Polymorphism outweighs the modest effect of deletional (–3.7 Kb) a-thalassemia on cholelithogenesis in sickle cell anemia vicky. Am J Hematol 82:807–811. https://doi.org/10.1002/ajh20574CrossRefPubMed

72.

Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, Grandison Y, Lowrie Y, Mason KP, Serjeant BE, Serjeant GR (1982) The interaction of alpha-thalassemia and homozygous sickle-cell disease. N Engl J Med 306:1441–1446. https://doi.org/10.1056/NEJM198206173062402CrossRefPubMed

73.

Pandey S, Pandey S, Mishra RM, Sharma M, Saxena R (2011) Genotypic influence of α-deletions on the phenotype of Indian sickle cell anemia patients. Korean J Hematol 46:192–195. https://doi.org/10.5045/kjh.2011.46.3.192CrossRefPubMedPubMedCentral

74.

Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK (2010) Leg ulcers in sickle cell disease. Am J Hematol 85:831–833. https://doi.org/10.1002/ajh.21838CrossRefPubMedPubMedCentral

75.

Camilo-Araujo RF, Amancio OMS, Figueiredo MS et al (2014) Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia. Rev Bras Hematol Hemoter 36:334–339. https://doi.org/10.1016/j.bjhh.2014.06.002CrossRefPubMedPubMedCentral

76.

Olatunya OS, Albuquerque DM, Adekile A, Costa FF (2019) Influence of alpha thalassemia on clinical and laboratory parameters among nigerian children with sickle cell anemia. J Clin Lab Anal 33:10–12. https://doi.org/10.1002/jcla.22656CrossRef

77.

Rumaney MB, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Kengne AP, Ngogang J, Wonkam A (2014) The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One 9:1–10. https://doi.org/10.1371/journal.pone.0100516CrossRef

78.

Hoppe CC (2014) Inflammatory mediators of endothelial injury in sickle cell disease. Hematol Oncol Clin North Am 28:265–286. https://doi.org/10.1016/j.hoc.2013.11.006CrossRefPubMed

79.

Wonkam A, Rumaney MB, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Ngogang J (2014) Coinheritance of sickle cell anemia and α-thalassemia delays disease onset and could improve survival in cameroonian’s patients (Sub-Saharan Africa). Am J Hematol 89:664–665. https://doi.org/10.1002/ajh.23711CrossRefPubMed

80.

Fabry ME, Mears GJ, Patel P et al (1984) Dense cells in sickle cell anemia: the effect of gene interaction. Blood 64:1042–1046CrossRef

81.

Platt OS, Brambilla D, Rosse WF et al (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639–1644CrossRef

82.

Miller S, Sleeper L, Charles P et al (2000) Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 342:1612–1613. https://doi.org/10.1056/NEJM200005253422114CrossRef

83.

Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 84:363–376. https://doi.org/10.1097/01.md.0000189089.45003.52CrossRef

84.

Hanchard N, Elzein A, Trafford C, Rockett K, Pinder M, Jallow M, Harding R, Kwiatkowski D, McKenzie C (2007) Classical sickle beta-globin haplotypes exhibit a high degree of long-range haplotype similarity in African and Afro-Caribbean populations. BMC Genet 8:1–11. https://doi.org/10.1186/1471-2156-8-52CrossRef

85.

Alves AC, da Silva VAL, Dos Santos A, Serra MB, Marques FA, Cruz SMP, Barroso WA, de Oliveira RAG (2020) Sickle cell anemia in the state of Maranhão: a haplotype study. Ann Hematol 99:1225–1230. https://doi.org/10.1007/s00277-020-04048-9CrossRefPubMed

86.

Zago MA, Figueiredo MS, Ogo SH (1992) Bantu BS cluster haplotype predominates among Brazilian Blacks. Am J Phys Anthropol 298:295–298CrossRef

87.

Figueiredo MS, Kerbauy J, Gonçalves MS, Arruda VR, Saad STO, Sonati MF, Stoming T, Costa FF (1996) Effect of α-thalassemia and β-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol 53:72–76. https://doi.org/10.1002/(SICI)1096-8652(199610)53:2<72::AID-AJH3>3.0.CO;2-0CrossRefPubMed

88.

Cardoso GL, Guerreiro JF (2010) Molecular characterization of sickle cell anemia in the Northern Brazilian state of Pará. Am J Hum Biol 22:573–577. https://doi.org/10.1002/ajhb.21047CrossRef

89.

Filho ILS, Ribeiro GS, Pimenta-Bueno LM, Serpa MJA (2010) The frequency of β-globin gene haplotypes, α-thalassemia and genetic polymorphisms of methylenetetrahydrofolate reductase, factor V leiden and prothrombin genes in children with sickle cell disease in Rio de Janeiro, Brazil. Rev Bras Hematol Hemoter 32:76–78CrossRef

90.

da Silva MAL, Friedrisch JR, Bittar CM et al (2014) B-Globin gene cluster haplotypes and clinical severity in sickle cell anemia patients in Southern Brazil. Open J Blood Dis 04:16–23. https://doi.org/10.4236/ojbd.2014.42003CrossRef

91.

Leal Alexandra S, Martins Paulo Roberto, J., Balarin, Marly Aparecida S., Pereira, Gilberto A., & Resende, Gláucia Aparecida D. (2016) Haplotypes βs-globin and its clinical-haematological correlation in patients with sickle-cell anemia in Triângulo Mineiro, Minas Gerais, Brazil. J Bras Patol Med Lab 52(1):6–10. https://doi.org/10.5935/1676-2444.20160001CrossRef

92.

Powars D, Hiti A (1993) Sickle cell anemia. BS gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child 147:1197–1202. https://doi.org/10.1001/archpedi.1993.02160350071011CrossRefPubMed

93.

Rieder RF, Safaya S, Gillette P, Fryd S, Hsu H, Adams JG, Steinberg MH (1991) Effect of beta-globin gene cluster haplotype on the hematological and clinical features of sickle cell anemia. Am J Hematol 36:184–189CrossRef

94.

Ngo D, Bae H, Steinberg MH, Sebastiani P, Solovieff N, Baldwin CT, Melista E, Safaya S, Farrer LA, al-Suliman AM, Albuali WH, al Bagshi MH, Naserullah Z, Akinsheye I, Gallagher P, Luo HY, Chui DHK, Farrell JJ, al-Ali AK, Alsultan A (2013) Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype. Blood Cells Mol Dis 51:22–26. https://doi.org/10.1016/j.bcmd.2012.12.005CrossRefPubMedPubMedCentral

95.

Lettre G, Sankaran VG, Bezerra MAC, Araujo AS, Uda M, Sanna S, Cao A, Schlessinger D, Costa FF, Hirschhorn JN, Orkin SH (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci 105:11869–11874. https://doi.org/10.1073/pnas.0804799105CrossRefPubMed

96.

Bezerra MAC, Santos MNN, Araújo AS, Gomes YM, Abath FGC, Bandeira FMGC (2007) Molecular variations linked to the grouping of beta- and alpha-globin genes in neonatal patients with sickle cell disease in the State of Pernambuco, Brazil. Hemoglobin 31:83–88. https://doi.org/10.1080/03630260601057153CrossRefPubMed

97.

Gonçalves MS (2003) ß S -Haplotypes in sickle cell anemia patients from Salvador, Bahia , Northeastern Brazil. Braz J Med Biol Res 36:1283–1288CrossRef

98.

Adorno EV, Zanette A, Lyra I, Souza CC, Santos LF, Menezes JF, Dupuit MF, Almeida MNT, Reis MG, Gonçalves MS (2004) The beta-globin gene cluster haplotypes in sickle cell anemia patients from Northeast Brazil: a clinical and molecular view. Hemoglobin 28:267–271. https://doi.org/10.1081/HEM-120040310CrossRefPubMed

99.

Rodrigues DOW, Ribeiro LC, Sudário LC, Teixeira MTB, Martins ML, Pittella AMOL, Junior IOF (2016) Genetic determinants and stroke in children with sickle cell disease. J Pediatr 92:1–7. https://doi.org/10.1016/j.jped.2016.01.010CrossRef

100.

Bitoungui VJN, Pule GD, Hanchard N, Ngogang J, Wonkam A (2015) Beta-Globin gene haplotypes among Cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa? Omics 19:171–179. https://doi.org/10.1089/omi.2014.0134CrossRefPubMedPubMedCentral

101.

Bernaudin F, Arnaud C, Kamdem A, Hau I, Lelong F, Epaud R, Pondarré C, Pissard S (2018) Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea. Blood Adv 2:626–637. https://doi.org/10.1182/bloodadvances.2017014555CrossRefPubMedPubMedCentral

Titel: Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort
verfasst von: Betânia Lucena Domingues Hatzlhofer
Diego Antonio Pereira-Martins
Igor de Farias Domingos
Gabriela da Silva Arcanjo
Isabel Weinhäuser
Diego Arruda Falcão
Isabela Cristina Cordeiro Farias
Jéssica Vitória Gadelha de Freitas Batista
Luana Priscilla Laranjeira Prado
Jéssica Maria Florencio Oliveira
Thais Helena Chaves Batista
Marcondes José de Vasconcelos Costa Sobreira
Rodrigo Marcionilo de Santana
Amanda Bezerra de Sá Araújo
Manuela Albuquerque de Melo
Bruna Vasconcelos de Ancântara
Juan Luiz Coelho-Silva
Ana Beatriz Lucas de Moura Rafael
Danízia Menezes de Lima Silva
Flávia Peixoto Albuquerque
Magnun Nueldo Nunes Santos
Ana Cláudia dos Anjos
Fernando Ferreira Costa
Aderson da Silva Araújo
Antonio Roberto Lucena-Araújo
Marcos André Cavalcanti Bezerra
Publikationsdatum: 13.02.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 4/2021
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-021-04450-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma

Dynamic evaluation of the prognostic value of 18F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type

Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients

Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients